LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
CAS Number
862507-23-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2120753-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
Ask
View Details 
MBS2120753-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
Ask
View Details MBS2120753-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
Ask
View Details MBS2120753-04 1 mL
Cy3-Linked Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
Ask
View Details